Cosan, a connected chronic care management company helping providers extend care beyond the clinic, announced a $15 million strategic growth equity investment led by Ziegler Link-age Funds and The Specialty Alliance, the nation’s leading physician-led Healthcare Partnership Organization and a long-standing Cosan partner.
Health Technology Insights: Slone Partners Places Jeffrey Kasten as Chief Business Officer at Vertero Therapeutics
Cosan Secures Strategic Growth Investment to Scale AI-Enabled, Team-Based Virtual Care for Chronic Conditions.
The investment accelerates Cosan’s expansion of its AI-enabled, human-led virtual care platform, which empowers providers to deliver proactive, compassionate, and personalized support to individuals living with chronic conditions in between office visits. The funding will advance Cosan’s ability to scale its multidisciplinary care teams, enhance AI-driven insights, and support practices seeking to improve outcomes while strengthening operational efficiency.
Health Technology Insights: Hyperfine Announces Regulatory Approval of the Swoop System in India
“We’re proud to deepen our partnership with Cosan,” said Katie Schmitz, Managing Partner at Ziegler Link-age Funds. “Cosan is demonstrating how AI can amplify the human touch—closing care gaps, strengthening relationships, and delivering outcomes that matter to patients and providers.”
Dr. Paul Berggreen, Chief Strategy Officer at The Specialty Alliance, added: “Cosan has been an exceptional partner for supporting our patients between visits. As we broaden our services across GI, urology, rheumatology, and radiation oncology, their chronic care management model remains an essential resource.”
Cosan currently serves more than 130,000 patients nationwide and enrolls 300 new patients each day, helping practices expand chronic care programs without sacrificing empathy or clinical quality. Its AI tools synthesize patient data, surface rising risks, streamline workflows, and personalize engagement while allowing clinicians to stay focused on meaningful patient interactions.
“Our mission is to help providers deliver compassionate, high-quality care beyond the office,” said David Hunt, CEO of Cosan. “AI allows us to extend the reach of care teams, not replace them. This investment strengthens our ability to deliver connected, timely, and personal care that improves lives.”
Cosan’s approach supports the healthcare industry’s shift toward proactive, value-based chronic disease management—bringing together advanced automation with real human connection.
Health Technology Insights: Bioptimus Launches M-Optimus to Transform Biological AI
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
Source- businesswire
